In lab models of stroke, a research team showed that laser therapy improved blood flow in the brain and decreased stroke injury by stimulating the production of nitric oxide.
A literature review fleshes out key issues currently preventing the proliferation of robotic procedures, specifically their use in image-guided interventional procedures in the brain.
Doctors work on initiatives to cut down the steps that need to happen between the time a stroke patient is wheeled through the ambulance bay until treatment can begin.
A commonly available imaging technique can identify stroke patients most likely to benefit from a procedure to restore blood flow, a potential breakthrough in care that could save thousands of lives every year
With interventional procedures becoming more and more complex the demands on the interventionalists are also increasing. Endovascular simulators allow practical angiography training. In December 2020, the University Hospital Essen, Germany, was the first European facility to install Mentice’s VIST G7+. Professor Dr Jens Theysohn, senior physician at the Institute of Diagnostic and…
Acute stroke in children has the same incidence as brain tumours and can seriously affect a patient’s life. Two kinds of arteriopathies are common drivers of paediatric acute stroke and radiologists must learn to distinguish their signs as early as possible to improve prognosis, according to Béatrice Husson, a paediatric radiologist at Le Kremlin Bicêtre Hospital in Paris.
There are major complications from COVID-19 – ARDS, pulmonary embolism and neurological – that imaging can help detect, manage and/or follow up in the long term, radiologists from France and the UK explained during a recent ESR Connect session. ARDS is the most dreaded complication and the number one morbidity in COVID-19 patients. The incidence was up to 30% of patients in initial reports.…
'Image Computing, including image analysis, artificial intelligence, artificial neural networks und deep learning, is starting a revolution,’ says Dr Paul Suetens, professor of Medical Imaging and Image Processing at University Hospital Leuven. Artificial Intelligence (AI) is not new – research in this field was carried out as far back as the 1950s – but, whilst in the early days AI learnt…
Treating stroke has long been governed by the clock. If it has been less than three hours since the onset of symptoms, the clot-busting drug t-PA will likely work. If it has been four and a half hours, some selected patients might benefit. However, if it has been more than six hours, treatment options have been few. Now that conventional wisdom has been turned on its head. The final results of…
They did it for heart attacks. Can cardiologists now lead an effort to speed up the emergency medical response for stroke? Over the past five years, the Stent for Life initiative organised by interventional cardiologists has pushed majors medical centres to assure 24/7 coverage and reduce the time to treatment for patients showing up with severe chest pain.
Results from six international randomised controlled studies conclusively and uniformly confirm, for the very first time, the effectiveness of thrombectomy in patients with acute, severe ischaemic strokes caused by a blood clot in one of the proximal cerebral arteries. The endovascular procedure is an add-on to conventional thrombolysis. EH reports from a German Stroke Society (DSG) press…
A research paper published in the New England Journal of Medicine (NEJM) today confirms earlier findings that a procedure called endovascular therapy (ET) for ischemic stroke is the best treatment option for many patients by reducing the incidents of disability. This is the fourth research paper published this year that confirms the efficacy of the treatment.
Stroke resulting from rupture or interruption of blood flow in brain vessels can lead to devastating consequences for patients, their families and society. Steady progress has been achieved in the last 20 years in stroke treatment through better prevention, establishment of stroke care units and the use of clot-busting drugs (intravenous thrombolysis).
Bayer HealthCare has entered into a definitive agreement to sell its Interventional device business to Boston Scientific for $415 million (about EUR 300 million), including fees for transitional services. The sale will include the AngioJet (thrombectomy) and Jetstream (atherectomy) systems, and the Fetch2 Aspiration Catheter used in cardiology, radiology and peripheral vascular procedures.
As announced today, MEDRAD, an affiliate of Bayer HealthCare and a leading provider of contrast injection systems used to diagnose cardiovascular disease, has entered into a definitive merger agreement with Possis Medical, leading provider of mechanical thrombectomy devices used to treat narrowed or blocked blood vessels. MEDRAD will acquire Possis Medical in a cash tender offer for US-Dollar…